Gait speed and muscle mass have been independently associated with both white matter hyperintensities (WMH) and Alzheimer's disease (AD), indicating complex interrelationships among these factors.
Objective
This study aims to investigate how gait speed and muscle mass function as mediators in the association between WMH and AD.
Methods
A total of 257 participants comprising 165 individuals with AD and 92 cognitively normal controls were included in this study. All participants underwent clinical evaluations, including volumetric brain magnetic resonance imaging and neuropsychological testing with the Korean version of CERAD Packet. WMH volume was calculated using automated segmentation analysis from 3D MRI images. Gait speed was measured using a timed 4-meter walk. Appendicular skeletal muscle mass (ASM) was measured using the bioelectrical impedance analysis.
Results
Multivariate logistic regression analysis revealed that slower gait speed (OR: 0.98, 95% CI: 0.95–0.998), lower ASM index (ASMI) (OR: 0.49, 95% CI: 0.26–0.93), and greater WMH volume (OR = 1.07; 95% CI: 1.01–1.14) were significantly associated with AD. Significant negative correlations were observed between gait speed and WMH volume (β = −0.32, p < 0.001), and between ASMI and WMH volume (β = −0.20, p = 0.022). Path analysis provided further clarification of the interrelationships, revealing that gait speed and ASMI emerged as significant mediators through their combined indirect effect (β = 0.20, 95% CI: 0.13–0.28) within the WMH-AD pathway.
Conclusions
Our findings demonstrate that both gait speed and muscle mass play crucial roles as dual mediators, negatively influencing the pathway connecting WMH to AD.
DeTureMADicksonDW. The neuropathological diagnosis of Alzheimer's disease. Mol Neurodegener2019; 14: 32.
2.
LeeSViqarFZimmermanME, et al.White matter hyperintensities are a core feature of Alzheimer's disease: evidence from the dominantly inherited Alzheimer network. Ann Neurol2016; 79: 929–939.
3.
Garnier-CrussardACottonFKrolak-SalmonP, et al.White matter hyperintensities in Alzheimer's disease: beyond vascular contribution. Alzheimers Dement2023; 19: 3738–3748.
4.
DebetteSMarkusHS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. Br Med J2010; 341: c3666.
5.
PrinsNDScheltensP. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol2015; 11: 157–165.
6.
LiQSuSFengY, et al.Potential role of blood pressure variability and plasma neurofilament light in the mechanism of comorbidity between Alzheimer's disease and cerebral small vessel disease. Alzheimers Dement2024; 20: 4891–4902.
7.
CollyerTAMurrayAMWoodsRL, et al.Association of dual decline in cognition and gait speed with risk of dementia in older adults. JAMA Netw Open2022; 5: e2214647.
8.
PeelNMAlapattLJJonesLV, et al.The association between gait speed and cognitive status in community-dwelling older people: a systematic review and meta-analysis. J Gerontol A Biol Sci Med Sci2019; 74: 943–948.
9.
VazquezJPVergheseJBarzilaiN, et al.White matter hyperintensities are associated with slower gait speed in older adults without dementia. Neurodegener Dis2024; 24: 97–105.
10.
SuCYangXWeiS, et al.Association of cerebral small vessel disease with gait and balance disorders. Front Aging Neurosci2022; 14: 834496.
11.
TessierAJWingSSRahmeE, et al.Association of low muscle mass with cognitive function during a 3-year follow-up among adults aged 65 to 86 years in the Canadian Longitudinal Study on Aging. JAMA Netw Open2022; 5: e2219926.
12.
BrisendineMHDrakeJC. Early-stage Alzheimer's disease: are skeletal muscle and exercise the key?J Appl Physiol (1985)2023; 134: 515–520.
13.
KoharaKOkadaYOchiM, et al.Muscle mass decline, arterial stiffness, white matter hyperintensity, and cognitive impairment: Japan Shimanami Health Promoting Program study. J Cachexia Sarcopenia Muscle2017; 8: 557–566.
14.
RosarioBLRossoALAizensteinHJ, et al.Cerebral white matter and slow gait: contribution of hyperintensities and normal-appearing parenchyma. J Gerontol A Biol Sci Med Sci2016; 71: 968–973.
ZhangKZhangKLiuQ, et al.The relationship between sarcopenia, cognitive impairment, and cerebral white matter hyperintensity in the elderly. Clin Interv Aging2023; 18: 547–555.
17.
SanaeifarFPourranjbarSPourranjbarM, et al.Beneficial effects of physical exercise on cognitive-behavioral impairments and brain-derived neurotrophic factor alteration in the limbic system induced by neurodegeneration. Exp Gerontol2024; 195: 112539.
18.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed.Arlington, VA: American Psychiatric Publishing, 2013.
19.
HanJWKimTHKwakKP, et al.Overview of the Korean longitudinal study on cognitive aging and dementia. Psychiatry Investig2018; 15: 767–774.
20.
LeeJHLeeKULeeDY, et al.Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci2002; 57: P47–P53.
21.
BaeJNChoMJ. Development of the Korean version of the Geriatric Depression Scale and its short form among elderly psychiatric patients. J Psychosom Res2004; 57: 297–305.
22.
CharlsonMEPompeiPAlesKL, et al.A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis1987; 40: 373–383.
23.
BergLMcKeelDWMillerJP, et al.Clinicopathologic studies in cognitively healthy aging and Alzheimer disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol1998; 55: 326–335.
Sri-OnJFusakulYKredarunsooksreeT, et al.The prevalence and risk factors of sarcopenia among Thai community-dwelling older adults as defined by the Asian Working Group for Sarcopenia (AWGS-2019) criteria: a cross-sectional study. BMC Geriatr2022; 22: 786.
26.
SchmidtP. Bayesian inference for structured additive regression models for large-scale problems with applications to medical imaging. Dissertation, LMU München, Germany: Faculty of Mathematics, 2017.
27.
LiTRLiBLXuXR, et al.Association of white matter hyperintensities with cognitive decline and neurodegeneration. Front Aging Neurosci2024; 16: 1412735.
28.
BrickmanAMProvenzanoFAMuraskinJ, et al.Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol2012; 69: 1621–1627.
29.
AgrawalSSchneiderJA. Vascular pathology and pathogenesis of cognitive impairment and dementia in older adults. Cereb Circ Cogn Behav2022; 3: 100148.
30.
RazLKnoefelJBhaskarK. The neuropathology and cerebrovascular mechanisms of dementia. J Cereb Blood Flow Metab2016; 36: 172–186.
31.
RasmussenLJHCaspiAAmblerA, et al.Association of neurocognitive and physical function with gait speed in midlife. JAMA Netw Open2019; 2: e1913123.
32.
ShimHKimMWonCW. Motoric cognitive risk syndrome is associated with processing speed and executive function, but not delayed free recall memory: the Korean Frailty and Aging Cohort Study (KFACS). Arch Gerontol Geriatr2020; 87: 103990.
33.
GrandeGTrioloFNuaraA, et al.Measuring gait speed to better identify prodromal dementia. Exp Gerontol2019; 124: 110625.
34.
GrandeGVetranoDLKalpouzosG, et al.Brain changes and fast cognitive and motor decline in older adults. J Gerontol A Biol Sci Med Sci2023; 78: 326–332.
35.
OgamaNEndoHSatakeS, et al.Impact of regional white matter hyperintensities on specific gait function in Alzheimer's disease and mild cognitive impairment. J Cachexia Sarcopenia Muscle2021; 12: 2045–2055.
MengSJYuLJ. Oxidative stress, molecular inflammation and sarcopenia. Int J Mol Sci2010; 11: 1509–1526.
38.
de LimaEPTanakaMLamasCB, et al.Vascular impairment, muscle atrophy, and cognitive decline: critical age-related conditions. Biomedicines2024; 12: 2096.
39.
YangHJLeeSKohMJ, et al.The association of white matter hyperintensities with frailty in patients with very mild to moderate Alzheimer's disease. J Alzheimers Dis2021; 83: 1281–1289.
40.
BarnesJNPearsonAGCorkeryAT, et al.Exercise, arterial stiffness, and cerebral vascular function: potential impact on brain health. J Int Neuropsychol Soc2021; 27: 761–775.
41.
YenSWuHYWangY, et al.Revisiting the effects of exercise on cerebral neurovascular functions in rats using multimodal assessment techniques. iScience2023; 26: 106354.
42.
OttaviTPPepperEBatemanG, et al.Consensus statement for the management of incidentally found brain white matter hyperintensities in general medical practice. Med J Aust2023; 219: 278–284.
43.
FacalDBurgoCSpuchC, et al.Cognitive frailty: an update. Front Psychol2021; 12: 813398.
44.
SugimotoTAraiHSakuraiT. An update on cognitive frailty: its definition, impact, associated factors and underlying mechanisms, and interventions. Geriatr Gerontol Int2022; 22: 99–109.
